CHECKPOINT THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.055 USD | -0.72% |
|
+8.99% | -10.04% |
| 06-24 | Checkpoint Therapeutics Plans to Resubmit Application for Cancer Treatment Candidate | MT |
| 06-24 | Checkpoint Therapeutics Reaches BLA Alignment With FDA for Cosibelimab | DJ |
Chart calendar Checkpoint Therapeutics, Inc.
c6542.ZIOzi77DkzQ62WnA8qXlZgstEd_xI-3T8LKaFIxrfVU.FNXyzN26vlVQllmYgpyLEENcfbSSbL7gtMXeet0IP2xXrvXc8ommUE2TIA~76e8f723e219ce8fd0301107070ae071
Upcoming events on Checkpoint Therapeutics, Inc.
Past events on Checkpoint Therapeutics, Inc.
| 20/05/2024 17:30 | H.C. Wainwright BioConnect Investor Conference |
| 13/05/2024 15:00 | Annual General Meeting |
| 10/05/2024 13:30 | Q1 2024 Earnings Release |
| 22/03/2024 12:30 | Q4 2023 Earnings Release |
| 18/01/2024 21:00 | B. Riley Securities Oncology Conference |
| 13/11/2023 22:00 | Q3 2023 Earnings Release |
| 28/09/2023 15:20 | Cantor Global Healthcare Conference |
| 11/09/2023 19:30 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 21:15 | Q2 2023 Earnings Release |
| 12/06/2023 15:00 | Annual General Meeting |
| 15/05/2023 21:15 | Q1 2023 Earnings Release |
| 30/03/2023 | Q4 2022 Earnings Release |
| 18/01/2023 16:00 | B. Riley Securities Oncology Conference |
| 03/11/2022 | Q3 2022 Earnings Release (Projected) |
| 29/09/2022 15:30 | Ladenburg Thalmann Healthcare Conference |
| 28/09/2022 18:45 | Cantor Oncology, Hematology & HemeOnc Conference |
| 13/09/2022 | Lake Street Capital Markets Best Ideas Growth Conference |
| 13/09/2022 13:30 | H.C. Wainwright Global Investment Conference |
| 12/08/2022 13:00 | Interim 2022 Earnings Release |
| 15/06/2022 15:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,71 2,09 -18.45% | 1,07 1,11 -3.74% | 0,27 0,36 -25.72% | 0,19 0,15 30.43% | 0,10 0,12 -16.6% | 0,03 |
|
EBITDA Million USD | Released Forecast Spread | -24,9 -21,4 -16.12% | -23,2 -18,0 -28.89% | -56,7 -33,8 -67.82% | -58,3 -41,3 -41.24% | -52,1 -67,2 22.4% | -45,6 |
|
EBIT Million USD | Released Forecast Spread | -24,9 -22,3 -11.31% | -23,2 -18,1 -28.13% | -56,7 -38,6 -47.06% | -58,3 -52,7 -10.67% | -52,1 -57,4 9.22% | -46,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,7 -22,3 -11.04% | -23,1 -18,0 -28% | -56,7 -38,7 -46.55% | -62,6 -54,7 -14.42% | -51,8 -48,9 -6.12% | -45,4 |
|
Net income Million USD | Released Forecast Spread | -24,7 -22,3 -11.04% | -23,1 -18,0 -28% | -56,7 -38,7 -46.47% | -62,6 -53,9 -16.25% | -51,8 -48,9 -6.12% | -45,4 |
|
EPS USD | Released Forecast Spread | -7,00 -6,50 -7.69% | -4,10 -3,23 -27.13% | -7,50 -5,08 -47.64% | -7,09 -4,73 -49.96% | -3,17 -2,68 -18.28% | -1,24 |
| Announcement Date | 11/03/20 | 09/03/21 | 28/03/22 | 31/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,05 0,00 - | 0,02 0,01 28.57% | 0,05 0,00 - | 0,07 0,03 131.25% | 0,04 0,01 180% | 0,03 0,01 520% | 0,03 0,01 148% | 0,01 0,02 -73.33% | 0,00 0,01 - | 0,01 | 0,01 | 0,01 | 4,53 | 15,0 |
|
EBITDA Million USD | Released Forecast Spread | -14,2 -11,0 -28.76% | -16,6 -4,00 -316.1% | -18,1 -14,8 -22.18% | -16,2 -15,7 -3.15% | -16,3 | -10,2 -17,1 40.53% | -10,9 -10,5 -4.27% | -11,2 | -11,5 | -11,9 | ||||
|
EBIT Million USD | Released Forecast Spread | -16,9 -12,1 -39.04% | -14,2 -14,0 -1.41% | -10,7 -13,5 21.09% | -16,6 -14,8 -12.33% | -18,1 -13,6 -33.19% | -16,2 -14,1 -14.86% | -7,70 -14,8 48.13% | -10,2 -10,6 3.82% | -10,9 -7,23 -51.46% | -11,1 | -11,4 | -12,8 | -6,89 | 0,11 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,8 -12,1 -38.93% | -14,1 -14,6 2.99% | -10,6 -13,5 21.47% | -21,0 -13,1 -60.37% | -10,5 -14,0 24.92% | -16,5 -14,5 -13.94% | -5,72 -15,7 63.62% | -19,1 -13,7 -39.4% | -10,9 -8,25 -32.63% | -10,9 | -11,3 | -12,3 | -6,89 | 0,11 |
|
Net income Million USD | Released Forecast Spread | -16,8 -12,1 -38.93% | -14,1 -14,3 1.39% | -10,6 -13,5 21.47% | -21,0 -13,1 -60.37% | -10,5 -14,0 24.92% | -16,5 -14,5 -13.94% | -5,72 -15,7 63.62% | -19,1 -13,7 -39.4% | -10,9 -8,25 -32.63% | -10,9 | -11,3 | -12,3 | -6,89 | 0,11 |
|
EPS USD | Released Forecast Spread | -2,00 -1,45 -37.93% | -1,60 -1,62 1.23% | -1,20 -1,47 18.18% | -6,61 -1,31 -406.13% | -0,89 -1,07 16.56% | -1,05 -0,78 -34.62% | -0,29 -0,76 61.84% | -1,10 -0,58 -91.3% | -0,33 -0,27 -20.73% | -0,31 | -0,31 | -0,31 | -0,15 | 0,00 |
| Announcement Date | 12/05/22 | 12/08/22 | 08/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 22/03/24 | 10/05/24 | - | - | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Checkpoint Therapeutics, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CKPT Stock
- Calendar Checkpoint Therapeutics, Inc.
